Literature DB >> 678425

Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.

M L Laursen, K Laursen.   

Abstract

Over the past 70 years many experiments have been designed to promote tumour growth. These studies were all carried out in allogeneic tumour systems or by artificially influencing the immunization process. In the present study, the growth of syngeneic mammary tumour cells was enhanced by prior immunization via the intracaecal route. Such induced enhancement could be transferred to untreated animals by serum or by spleen cells. Tumour growth was also enhanced in another syngeneic system by immunization via the intestinal route with frozen-thawed ascites tumour cells. The result is in direct contrast to that obtained by similar immunization with live cells, which affords protection against a later challenge.

Entities:  

Mesh:

Year:  1978        PMID: 678425      PMCID: PMC2009641          DOI: 10.1038/bjc.1978.151

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  10 in total

1.  EFFECT ON TUMOUR GROWTH IN SYNGENEIC RECIPIENTS OF ANTIBODIES AGAINST TUMOUR-SPECIFIC ANTIGENS IN METHYLCHOLANTHRENE-INDUCED MOUSE SARCOMAS.

Authors:  G MOLLER
Journal:  Nature       Date:  1964-11-28       Impact factor: 49.962

2.  Immunological enhancement of tumor homografts in mice: a review.

Authors:  N KALISS
Journal:  Cancer Res       Date:  1958-10       Impact factor: 12.701

3.  A correlation between electrical surface charge and some biological characteristics during the stepwise progression of a mouse sarcoma.

Authors:  L PURDOM; E J AMBROSE; G KLEIN
Journal:  Nature       Date:  1958-06-07       Impact factor: 49.962

4.  Regression or survival of tumor homoiografts in mice pretreated with injections of lyophilized tissues.

Authors:  N KALISS
Journal:  Cancer Res       Date:  1952-05       Impact factor: 12.701

5.  Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus.

Authors:  M A Attia; D W Weiss
Journal:  Cancer Res       Date:  1966-08       Impact factor: 12.701

Review 6.  Immunologic enhancement.

Authors:  G D Snell
Journal:  Surg Gynecol Obstet       Date:  1970-06

7.  Lymphocyte-antibody interactions in immunological enhancement.

Authors:  M Takasugi; W H Hildemann
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

8.  Immunization by the intestinal route of C3H-mice against C3H-L-ascites tumor cells.

Authors:  M L Laursen; K Laursen
Journal:  Proc Soc Exp Biol Med       Date:  1977-02

9.  Tumor-associated immunoglobulins. Enhancement of syngeneic tumors by IgG2-containing tumor eluates.

Authors:  M Ran; I P Witz
Journal:  Int J Cancer       Date:  1972-01-15       Impact factor: 7.396

10.  Vaccination of rats against the Yoshida ascites sarcoma with the formation of complement-fixing antibody.

Authors:  H J LUND
Journal:  Br J Cancer       Date:  1957-09       Impact factor: 7.640

  10 in total
  4 in total

1.  Dependence on antigen dose and timing in the immune response of C3H mice to malignant ascites cells.

Authors:  M L Laursen; K Laursen
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

2.  Is cyclophosphamide self-defeating as an antitumor agents?

Authors:  M L Laursen
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

3.  Immunological enhancement induced by gastrointestinal immunization of mice pretreated with cyclophosphamide.

Authors:  M L Laursen
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

4.  Serological response to intracaecal injections of antigenic mouse tumour cells.

Authors:  M L Laursen
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.